Archive: 28/06/2013

FDA approves rixubis for prophylactic tx in hemophilia B

(HealthDay)—Rixubis (coagulation factor IX recombinant) has been approved by the U.S. Food and Drug Administration to prevent routine bleeding episodes in people aged 16 and older with hemophilia B, the agency said in a ...

Can a contact lens help treat glaucoma?

While an undergraduate in biochemistry at McMaster, Michelle Fernandes worked as a researcher for a biotech company. Now a master's candidate in chemical engineering, she credits that co-op work experience with sparking her ...

page 3 from 5